Metabolomics-on-a-chip and predictive systems toxicology in microfluidic bioartificial organs.
Anal Chem
; 84(4): 1840-8, 2012 Feb 21.
Article
in En
| MEDLINE
| ID: mdl-22242722
ABSTRACT
The world faces complex challenges for chemical hazard assessment. Microfluidic bioartificial organs enable the spatial and temporal control of cell growth and biochemistry, critical for organ-specific metabolic functions and particularly relevant to testing the metabolic dose-response signatures associated with both pharmaceutical and environmental toxicity. Here we present an approach combining a microfluidic system with (1)H NMR-based metabolomic footprinting, as a high-throughput small-molecule screening approach. We characterized the toxicity of several molecules ammonia (NH(3)), an environmental pollutant leading to metabolic acidosis and liver and kidney toxicity; dimethylsulfoxide (DMSO), a free radical-scavenging solvent; and N-acetyl-para-aminophenol (APAP, or paracetamol), a hepatotoxic analgesic drug. We report organ-specific NH(3) dose-dependent metabolic responses in several microfluidic bioartificial organs (liver, kidney, and cocultures), as well as predictive (99% accuracy for NH(3) and 94% for APAP) compound-specific signatures. Our integration of microtechnology, cell culture in microfluidic biochips, and metabolic profiling opens the development of so-called "metabolomics-on-a-chip" assays in pharmaceutical and environmental toxicology.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bioartificial Organs
/
Microfluidics
/
Drug-Related Side Effects and Adverse Reactions
/
Metabolomics
/
Ammonia
/
Acetaminophen
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Anal Chem
Year:
2012
Document type:
Article
Affiliation country: